Novacare Packaging Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 25 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.00 M
as on 24-12-2024
- Revenue -39.53%
(FY 2020)
- Profit -4304.08%
(FY 2020)
- Ebitda -2791.10%
(FY 2020)
- Net Worth -16.00%
(FY 2020)
- Total Assets -15.89%
(FY 2020)
About Novacare Packaging
The Corporate was formerly known as Novamark Specialities Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹8.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ramakrishnan Kannan and Hema Kannan serve as directors at the Company.
- CIN/LLPIN
U24230MH1999PTC119467
- Company No.
119467
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Novacare Packaging?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramakrishnan Kannan  | Director | 16-Apr-1999 | Current |
| Hema Kannan | Director | 16-Apr-1999 | Current |
Financial Performance of Novacare Packaging.
Novacare Packaging Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 39.53% decrease. The company also saw a substantial fall in profitability, with a 4304.08% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novacare Packaging?
In 2019, Novacare Packaging had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Novacare Drug Specialities Private LimitedActive 32 years 6 monthsRamakrishnan Kannan and Hema Kannan are mutual person
- Medworld Pharmaceuticals Private LimitedActive 18 years 6 months
Ramakrishnan Kannan and Hema Kannan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 Jul 2012 | ₹8.00 M | Satisfied |
How Many Employees Work at Novacare Packaging?
Unlock and access historical data on people associated with Novacare Packaging, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novacare Packaging, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novacare Packaging's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
